Leveljump Healthcare Corp. announces a minority investment of 13.1% in the real-time medical field

Toronto, Ontario – (Newsfile Corp. – November 24, 2021) – Leveljump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) (“Leveljump” or the “Company”), a Canadian leader in B2B Telehealth Solutions, is pleased to announce that, subject to the regulatory approval, it agreed to acquire an outstanding 13.1% minority interest in Real Time Medical Inc. (“RTM”), a privately held Ontario company, in exchange for 2,244,576 units (a “Unit”) of Leveljump. Each unit will be issued at a price of $ 0.66 per unit, each unit being composed of three (3) common shares of Leveljump at a deemed price of $ 0.22 per share and one (1) warrant. Leveljump share, each warrant entitling to purchase one additional Leveljump common share at a price of $ 0.35 per common share on or before December 31, 2023.

The stake in RTM was acquired as part of a mini-takeover bid to RTM shareholders dated November 1, 2021, whereby JUMP offered to acquire up to 19.9% ​​of RTM in exchange for the parts. The holders of RTM shares who have contributed are all qualified investors.

“We are very excited about this investment and believe that with teleradiology operations and Real Time services in several provinces across Canada there is a natural complement to our core CTS operations,” said Mitchell Geisler, head of the management of the company. “We are focused on expanding our telehealth solutions and providing critical care radiology support and this investment is another step in the growth of our business. “

Closing of the RTM Offer is subject to the consent of the TSX Venture Exchange and the approval of RTM’s Board of Directors, which has been obtained.

All securities issued will be subject to a four month and one day hold period in accordance with applicable securities laws.

About real-time medicine

Real Time Medical is a company created by clinicians, for clinicians. Its founders include three Canadian radiologists and a former GE PACS executive. The vision is to develop and operate a nationwide radiology collaboration service for Canadian radiologists, with patented diagnostic workload balancing, workflow orchestration, learning software. peer and diagnostic operations. The service network was launched in 2008.

About Leveljump Healthcare

Leveljump Healthcare Corp., (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) is a healthcare company focused on cost-effective telehealth solutions as well as primary care radiology services. The Company’s subsidiary, CTS, provides offsite x-ray readings for hospital emergency rooms and is a leader in teleradiology in Ontario. As part of our growth strategy, we are acquiring healthcare companies that have strong revenues and cash flows, with room for organic growth.


Mitchell Geisler, President and CEO
[email protected]
(833) 840-2020


This press release contains “forward-looking information” within the meaning of applicable securities laws relating to the business plans of the Company and the outlook for the Company’s industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been deemed appropriate, that the expectations reflected in this forward-looking information are reasonable, it do not place undue reliance on them because the Company cannot guarantee that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements contained in this press release are made as of the date of this press release and the Company assumes no responsibility to update or revise them to reflect new events or circumstances other than those required by securities laws. applicable movable property. The Company assumes no obligation to comment on any analyzes, expectations or statements made by third parties with respect to the Company, Canadian Teleradiology Services, Inc., their titles or their respective financial or operational results (if any).

Neither the Bourse nor its regulatory services provider (as that term is defined in the policies of the Bourse) accepts responsibility for the adequacy or accuracy of this release.

The securities offered have not been and will not be registered under the United States Securities Act of 1933, as amended (the “US Securities Act”) or any United States securities law, and may not be offered or sold in the United States. United States or to, or on behalf of or for the benefit of, persons of the United States without registration or applicable exemption from the registration requirements of the US Securities Act and applicable United States securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any other jurisdiction.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/105010

Comments are closed.